Comparative Evaluation of Lactulose and Bisacodyl in the Management of Chronic Constipation: Efficacy, Safety, and Patient Preferences
Chronic constipation is a common gastrointestinal disorder, and its management often requires long-term use of laxatives. This review addresses the differences between two commonly used laxatives, lactulose and bisacodyl. The efficacy, side effect profiles, tolerance development, use in special popu...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2023-12-01
|
Series: | Bagcilar Medical Bulletin |
Subjects: | |
Online Access: |
http://behmedicalbulletin.org/archives/archive-detail/article-preview/comparative-evaluation-of-lactulose-and-bisacodyl-/63452
|
_version_ | 1797386010802257920 |
---|---|
author | Mustafa Reşat Dabak Kerim Güler |
author_facet | Mustafa Reşat Dabak Kerim Güler |
author_sort | Mustafa Reşat Dabak |
collection | DOAJ |
description | Chronic constipation is a common gastrointestinal disorder, and its management often requires long-term use of laxatives. This review addresses the differences between two commonly used laxatives, lactulose and bisacodyl. The efficacy, side effect profiles, tolerance development, use in special populations, drug interactions, contraindications, and impacts on patient compliance and quality of life of these two laxatives are compared. Both lactulose and bisacodyl are effective in improving bowel movements and are widely used in clinical practice. However, lactulose might present a more favorable profile for certain patient populations when considering factors such as side effect profile, patient compliance, quality of life, and cost-effectiveness. Primary care physicians should consider these aspects when choosing the most appropriate treatment option for their patients, always considering individual patient characteristics and preferences. |
first_indexed | 2024-03-08T22:02:40Z |
format | Article |
id | doaj.art-f05d62dfbc654b6c934e1675ac9f53be |
institution | Directory Open Access Journal |
issn | 2547-9431 |
language | English |
last_indexed | 2024-03-08T22:02:40Z |
publishDate | 2023-12-01 |
publisher | Galenos Yayinevi |
record_format | Article |
series | Bagcilar Medical Bulletin |
spelling | doaj.art-f05d62dfbc654b6c934e1675ac9f53be2023-12-19T10:59:55ZengGalenos YayineviBagcilar Medical Bulletin2547-94312023-12-018433534010.4274/BMB.galenos.2023.2023-08-07313049054Comparative Evaluation of Lactulose and Bisacodyl in the Management of Chronic Constipation: Efficacy, Safety, and Patient PreferencesMustafa Reşat Dabak0Kerim Güler1 University of Health Sciences Turkey, İstanbul Haseki Training and Research Hospital, Clinic of Family Medicine, İstanbul, Turkey İstanbul University, İstanbul Faculty of Medicine, Department of Internal Medicine, İstanbul, Turkey Chronic constipation is a common gastrointestinal disorder, and its management often requires long-term use of laxatives. This review addresses the differences between two commonly used laxatives, lactulose and bisacodyl. The efficacy, side effect profiles, tolerance development, use in special populations, drug interactions, contraindications, and impacts on patient compliance and quality of life of these two laxatives are compared. Both lactulose and bisacodyl are effective in improving bowel movements and are widely used in clinical practice. However, lactulose might present a more favorable profile for certain patient populations when considering factors such as side effect profile, patient compliance, quality of life, and cost-effectiveness. Primary care physicians should consider these aspects when choosing the most appropriate treatment option for their patients, always considering individual patient characteristics and preferences. http://behmedicalbulletin.org/archives/archive-detail/article-preview/comparative-evaluation-of-lactulose-and-bisacodyl-/63452 bisacodylconstipationlactuloselaxativeosmoticpurgativestimulant |
spellingShingle | Mustafa Reşat Dabak Kerim Güler Comparative Evaluation of Lactulose and Bisacodyl in the Management of Chronic Constipation: Efficacy, Safety, and Patient Preferences Bagcilar Medical Bulletin bisacodyl constipation lactulose laxative osmotic purgative stimulant |
title | Comparative Evaluation of Lactulose and Bisacodyl in the Management of Chronic Constipation: Efficacy, Safety, and Patient Preferences |
title_full | Comparative Evaluation of Lactulose and Bisacodyl in the Management of Chronic Constipation: Efficacy, Safety, and Patient Preferences |
title_fullStr | Comparative Evaluation of Lactulose and Bisacodyl in the Management of Chronic Constipation: Efficacy, Safety, and Patient Preferences |
title_full_unstemmed | Comparative Evaluation of Lactulose and Bisacodyl in the Management of Chronic Constipation: Efficacy, Safety, and Patient Preferences |
title_short | Comparative Evaluation of Lactulose and Bisacodyl in the Management of Chronic Constipation: Efficacy, Safety, and Patient Preferences |
title_sort | comparative evaluation of lactulose and bisacodyl in the management of chronic constipation efficacy safety and patient preferences |
topic | bisacodyl constipation lactulose laxative osmotic purgative stimulant |
url |
http://behmedicalbulletin.org/archives/archive-detail/article-preview/comparative-evaluation-of-lactulose-and-bisacodyl-/63452
|
work_keys_str_mv | AT mustafaresatdabak comparativeevaluationoflactuloseandbisacodylinthemanagementofchronicconstipationefficacysafetyandpatientpreferences AT kerimguler comparativeevaluationoflactuloseandbisacodylinthemanagementofchronicconstipationefficacysafetyandpatientpreferences |